{
  "docId": "019de073-ceb7-7719-9dd4-8c66dbfaed37",
  "docSlug": "b2317289d3b06d938a683c10bc0d40e0",
  "documentTitle": "Organicell Regenerative Medicine | Investor Presentation Deck | 17 slides",
  "authorId": "organicell-regenerative-medicine",
  "authorName": "Organicell Regenerative Medicine",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 5,
  "pageCount": 17,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "executive_summary",
  "function": "summarize",
  "density": "overcrowded",
  "nDataPoints": 4,
  "notes": "The slide uses a timeline-based strategic roadmap to outline short, mid, and long-term business goals.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-ceb7-7719-9dd4-8c66dbfaed37/5",
  "deckHref": "/decks/019de073-ceb7-7719-9dd4-8c66dbfaed37",
  "deckJsonHref": "/decks/019de073-ceb7-7719-9dd4-8c66dbfaed37.json",
  "deckAnchorHref": "/decks/019de073-ceb7-7719-9dd4-8c66dbfaed37#slide-5",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.86,
        "x": 0.07,
        "y": 0.46
      },
      "kind": "framework",
      "text": "Short Term (12 Months) | Mid Term (24 Months) | Long Term",
      "attrs": null,
      "subkind": "instance",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ca7f239a-b638-402e-818e-1e2602242578",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.28,
        "x": 0.07,
        "y": 0.58
      },
      "kind": "list",
      "text": "Health and Beauty Partnerships: Generate revenue to offset costs. Markets: Facial Market, Micro Needling, Hair Restoration, Topical Procedure Aftercare.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "13e0bf71-cf64-45e1-832d-7d93b14faaa0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.28,
        "x": 0.37,
        "y": 0.58
      },
      "kind": "list",
      "text": "Clinical Trials to pursue a Biologics License Application (BLA): The completion of clinical trials and issuance of a BLA will enable Organicell to distribute its flagship therapeutics nationwide and make medical claims on therapeutic efficacy.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "440267ae-8104-4e1d-82bf-4718c1f241a8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.28,
        "x": 0.67,
        "y": 0.58
      },
      "kind": "list",
      "text": "Evolve the science to address other specific ailments: Long Covid, COPD, Osteoarthritis, Sports Injury, Skin Irritations, other anti-inflammatory uses.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c7cb1f23-cb38-4535-980a-c33fa2929dc5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.86,
        "x": 0.07,
        "y": 0.15
      },
      "kind": "paragraph",
      "text": "Organicell is a clinical research company. Our mission is to be the first company to prove the efficacy of extracellular vesicles in clinical trials for several conditions. The Company generates revenue by extracting and delivering potent formulas of EVs for topical applications.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "075b8df6-9fa3-443f-805c-ddac9a279ffa",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.86,
        "x": 0.07,
        "y": 0.3
      },
      "kind": "paragraph",
      "text": "Organicell's flagship therapeutic, Zofin™, is naturally derived and therefore only required to be clinically tested on 30 patients to complete Phase I/II trials. Significantly for milestones, Phase III trials require only 200 patients. Clinical trials are currently enrolling and anticipated to be completed within 24 months.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0f44eb5e-4ed5-4e73-9bac-a48f16aa76ad",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.25,
        "x": 0.07,
        "y": 0.04
      },
      "kind": "title",
      "text": "Business Overview",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "46185192-46ed-47f3-b0ac-7efad6570e6f",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Executive summary",
      "slug": "executive-summary",
      "agent": null,
      "layer": "slide",
      "matchId": "9573e11b-54cf-4283-8f94-43761eaa084f",
      "evidence": "The slide is labeled as 'Business Overview' and contains a type 'executive_summary'.",
      "confidence": 0.9
    }
  ],
  "frameworks": [
    {
      "name": "timeline",
      "slug": null,
      "matchId": "cb42f976-2570-497e-953a-94d080a09181",
      "evidence": "The slide uses a horizontal arrow structure to delineate strategic phases over time.",
      "confidence": 1
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}